8-KThe WireRoutine
Shareholder Vote
Filed Jun 24, 2026 · 5d ago · Accession 0001193125-26-281051
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kymera Therapeutics, Inc.
- Ticker
- KYMR
- CIK
- 1815442
- Form type
- 8-K
- Filing date
- Jun 24, 2026
- Report date
- Jun 24, 2026
- Document
- d131538d8k.htm
- Size
- 150 KB